GlassScriptPhysician profile
Danielle Katrina Benosa
NPI 1265868723
$3,730.40
in general payments reported to CMS, 2019-2025
19 companies · $879 in 2025
The $879 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,921 · 2020: $139 · 2021: $103 · 2022: $261 · 2023: $278 · 2024: $150 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,573.96 | 2019-2025 | Dailies Total1, Precision 1, Clareon Panoptix Pro |
| Johnson & Johnson Vision Care, INC. | $589.17 | 2019-2025 | Acuvue |
| Abbvie INC. | $255.32 | 2023-2025 | Durysta |
| Sun Pharmaceutical Industries INC. | $158.82 | 2019-2022 | |
| Dompe US, INC. | $155.66 | 2021-2024 | Oxervate |
| Coopervision INC. | $145.94 | 2019-2025 | Myday Contact Lens |
| Regeneron Pharmaceuticals, INC. | $143.20 | 2025 | Eylea |
| Shire North American Group INC | $125.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $124.99 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $77.32 | 2022-2023 | Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $75.72 | 2019-2021 | |
| Allergan, INC. | $55.07 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $49.06 | 2020 | |
| Eyevance Pharmaceuticals LLC | $43.84 | 2019-2022 | |
| Rxsight INC | $41.32 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $39.90 | 2023-2024 | Iyuzeh |
| Biotissue Holdings INC. | $37.92 | 2019-2022 | |
| Sight Sciences, INC. | $20.95 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Benosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.